Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Correction to announcement no 11 - Managers’ transactions

Posted on: 10 Aug 17

BioPorto A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in BioPorto A/S made by persons discharging managerial responsibilities in BioPorto A/S and/or persons closely related with them.


1 Details of the person discharging managerial responsibilities/person closely associated  
a)       Name Thomas Magnussen
2 Reason for the notification  
a)       Position/status Chairman of the Board
b)      Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  
a)       Name BioPorto A/S
b)      LEI 5299004SWFL5JAN4W830
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
a)       Description of the financial instrument, type of instrument
Identification code
b)      Nature of the transaction Share purchase
c)       Price(s) and volume(s) Price DKK 3.06, Volume 100,000
d)      Aggregated information n/a
e)      Date of the transaction 2017-08-10
f)        Place of the transaction Nasdaq Copenhagen A/S, XCSE





Last updated on: 11/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.